PanCareSurPass Project HL7 FHIR Implementation Guide
1.0.0 - release 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

## ValueSet: Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp | Version: 1.0.0
Active as of 2025-10-16 | Computable Name: RiskCondition

Condition at risk proposed by the PCSP algorithm

References

- CarePlan: PCSP-generated plan

### Logical Definition (CLD)

- Include all codes defined in `http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` version 📦1.0.0

### Expansion

Expansion performed internally based on codesystem PCSP Conditions at risk v1.0.0 (CodeSystem)

This value set contains 47 concepts

System | Code | Display (en) | JSON | XML
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 1 | Subsequent thyroid cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 2 | Subsequent breast cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 3 | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 4 | Impaired fertility Impaired spermatogenesis |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 5 | Testosterone deficiency |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 6 | Physical sexual dysfunction |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 7 | Premature ovarian insufficiency |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 8 | Ear problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 9 | Impaired glucose metabolism and diabetes melitus |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 10 | Dyslipidemia |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 11 | Overweight and obesity |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 12 | Hypertension |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 13 | Reduced bone mineral density |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 14 | Osteonecrosis |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 15 | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 16 | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 17 | Central precocious puberty (CPP) For girls with age below 8 years |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 18 | Central precocious puberty (CPP) For boys with age below 9 yearss |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 19 | Thyroid function problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 20 | Cerebrovascular problem |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 21 | Neurocognitive problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 22 | Peripheral neuropathy |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 23 | Cataract |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 24 | Eye problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 25 | Craniofacial growth problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 26 | Spine scoliosis and kyphosis |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 27 | Lower urinary tract problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 28 | Obstetric problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 29 | Dental and oral problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 30 | Gastro-intestinal problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 31 | Arrhythmia |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 32 | Pulmonary problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 33 | Renal problems (Glomerular dysfunction - Tubular dysfunction) |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 34 | Liver problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 35 | Iron overload |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 36 | Spleen problems |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 37 | Tumor predisposition |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 38 | Subsequent melanoma and non-melanoma skin cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 39 | Subsequent colorectal cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 40 | Subsequent Oral Cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 41 | Subsequent acute myeloid leukaemia or myelodysplasia |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 42 | Subsequent bladder cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 43 | Subsequent Bone Cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 44 | Subsequent lung cancer |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 45 | Subsequent CNS neoplasms |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 46 | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |  |
`http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` | 47 | Renal problems (Tubular dysfunction) |  |

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code